105 related articles for article (PubMed ID: 26781922)
1. Inhibitory effects of several saturated fatty acids and their related fatty alcohols on the growth of Candida albicans.
Hayama K; Takahashi M; Yui S; Abe S
Drug Discov Ther; 2015 Dec; 9(6):386-90. PubMed ID: 26781922
[TBL] [Abstract][Full Text] [Related]
2. [Anti-Candida activity of aroma candy and its protective activity against murine oral candidiasis].
Hayama K; Takahashi M; Suzuki M; Ezawa K; Yamazaki M; Matsukawa T; Kishi A; Sato N; Abe S
Med Mycol J; 2015; 56(1):J23-9. PubMed ID: 25855024
[TBL] [Abstract][Full Text] [Related]
3. The Dietary Food Components Capric Acid and Caprylic Acid Inhibit Virulence Factors in Candida albicans Through Multitargeting.
Jadhav A; Mortale S; Halbandge S; Jangid P; Patil R; Gade W; Kharat K; Karuppayil SM
J Med Food; 2017 Nov; 20(11):1083-1090. PubMed ID: 28922057
[TBL] [Abstract][Full Text] [Related]
4. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
5. In vitro killing of Candida albicans by fatty acids and monoglycerides.
Bergsson G; Arnfinnsson J; Steingrímsson O ; Thormar H
Antimicrob Agents Chemother; 2001 Nov; 45(11):3209-12. PubMed ID: 11600381
[TBL] [Abstract][Full Text] [Related]
6. [The effects of an aroma candy on oral Candida albicans colony-forming units (CFU) and oral hygiene states in healthy elderly carrying Candida albicans].
Suzuki M; Hayama K; Takahashi M; Ezawa K; Yamazaki M; Matsukawa T; Kishi A; Satou N; Abe S
Med Mycol J; 2015; 56(1):J31-40. PubMed ID: 25855026
[TBL] [Abstract][Full Text] [Related]
7. [Effects of inhibitory activity on mycelial growth of Candida albicans and therapy for murine oral candidiasis by the combined use of terpinen-4-ol and a middle-chain fatty acid, capric acid].
Ninomiya K; Hayama K; Ishijima S; Takahashi M; Kurihara J; Abe S
Yakugaku Zasshi; 2013; 133(1):133-40. PubMed ID: 23292030
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of Candida mycelia growth by a medium chain fatty acids, capric acid in vitro and its therapeutic efficacy in murine oral candidiasis].
Takahashi M; Inoue S; Hayama K; Ninomiya K; Abe S
Med Mycol J; 2012; 53(4):255-61. PubMed ID: 23257726
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of Growth of Candida albicans by a Lysozyme-chitosan Conjugate, LYZOX and its Combination with Decanoic Acid].
Kageshima H; Hayama K; Takahashi M; Abe M; Yamada T; Saito A; Hirano S; Murakami Y; Abe S
Med Mycol J; 2017; 58(3):J63-J69. PubMed ID: 28855481
[TBL] [Abstract][Full Text] [Related]
10. Disparate Candida albicans Biofilm Formation in Clinical Lipid Emulsions Due to Capric Acid-Mediated Inhibition.
Willems HME; Stultz JS; Coltrane ME; Fortwendel JP; Peters BM
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31405860
[TBL] [Abstract][Full Text] [Related]
11. Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation.
Murzyn A; Krasowska A; Stefanowicz P; Dziadkowiec D; Łukaszewicz M
PLoS One; 2010 Aug; 5(8):e12050. PubMed ID: 20706577
[TBL] [Abstract][Full Text] [Related]
12. Effect of cinnamaldehyde on hyphal growth of C. albicans under various treatment conditions.
Taguchi Y; Hasumi Y; Hayama K; Arai R; Nishiyama Y; Abe S
Med Mycol J; 2012; 53(3):199-204. PubMed ID: 23149355
[TBL] [Abstract][Full Text] [Related]
13. Boric acid destabilizes the hyphal cytoskeleton and inhibits invasive growth of Candida albicans.
Pointer BR; Boyer MP; Schmidt M
Yeast; 2015 Apr; 32(4):389-98. PubMed ID: 25612315
[TBL] [Abstract][Full Text] [Related]
14. Candida albicans PHO81 is required for the inhibition of hyphal development by farnesoic acid.
Chung SC; Kim TI; Ahn CH; Shin J; Oh KB
FEBS Lett; 2010 Nov; 584(22):4639-45. PubMed ID: 20965180
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus mutans inhibits Candida albicans hyphal formation by the fatty acid signaling molecule trans-2-decenoic acid (SDSF).
Vílchez R; Lemme A; Ballhausen B; Thiel V; Schulz S; Jansen R; Sztajer H; Wagner-Döbler I
Chembiochem; 2010 Jul; 11(11):1552-62. PubMed ID: 20572249
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Candida albicans morphogenesis by fatty acid metabolites.
Noverr MC; Huffnagle GB
Infect Immun; 2004 Nov; 72(11):6206-10. PubMed ID: 15501745
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin.
Messier C; Epifano F; Genovese S; Grenier D
Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508
[TBL] [Abstract][Full Text] [Related]
18. Relationship between cell morphology and intracellular potassium concentration in Candida albicans.
Watanabe H; Azuma M; Igarashi K; Ooshima H
J Antibiot (Tokyo); 2006 May; 59(5):281-7. PubMed ID: 16883777
[TBL] [Abstract][Full Text] [Related]
19. Histone acetylation increases in response to ferulic, gallic, and sinapic acids acting synergistically in vitro to inhibit Candida albicans yeast-to-hyphae transition.
Câmara CRS; Shi Q; Pedersen M; Zbasnik R; Nickerson KW; Schlegel V
Phytother Res; 2019 Feb; 33(2):319-326. PubMed ID: 30375074
[TBL] [Abstract][Full Text] [Related]
20. Valinomycin affects the morphology of Candida albicans.
Watanabe H; Azuma M; Igarashi K; Ooshima H
J Antibiot (Tokyo); 2005 Dec; 58(12):753-8. PubMed ID: 16506692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
